The story of Viagra, and its developer copyright, presents a complex case study for investors. Initially a blockbuster drug, yielding billions in income, its patent expiration created a wave of lower-priced https://bookmarkingace.com/story21422712/sildenafil-and-big-pharma-a-uncertain-venture